loadpatents
name:-0.017006874084473
name:-0.0091838836669922
name:-0.0023798942565918
MUGRAGE; Benjamin Patent Filings

MUGRAGE; Benjamin

Patent Applications and Registrations

Patent applications and USPTO patent grants for MUGRAGE; Benjamin.The latest application filed is for "method for the treatment of pompe disease using 1-deoxynojirimycin derivatives".

Company Profile
2.11.13
  • MUGRAGE; Benjamin - Cranbury NJ
  • Mugrage; Benjamin - Cranburry NJ
  • - Cranbury NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For The Treatment Of Pompe Disease Using 1-deoxynojirimycin Derivatives
App 20180221357 - MUGRAGE; Benjamin ;   et al.
2018-08-09
Combination therapy with MDM2 and EFGR inhibitors
Grant 9,273,031 - Errico , et al. March 1, 2
2016-03-01
Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin Derivatives
App 20160051528 - Mugrage; Benjamin ;   et al.
2016-02-25
Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
Grant 9,181,184 - Mugrage , et al. November 10, 2
2015-11-10
Methods of targeted drug development
Grant 9,073,858 - Errico , et al. July 7, 2
2015-07-07
Combination therapy with MDM2 and EFGR inhibitors
Grant 9,023,354 - Errico , et al. May 5, 2
2015-05-05
Combination Therapy With Mdm2 And Efgr Inhibitors
App 20150105412 - Errico; Joseph P. ;   et al.
2015-04-16
Methods Of Targeted Drug Development
App 20140194439 - Errico; Joseph P. ;   et al.
2014-07-10
Methods And Compositions Of Targeted Drug Development
App 20140179681 - Errico; Joseph P. ;   et al.
2014-06-26
Compositions Of Targeted Drug Development
App 20140163069 - Errico; Joseph P. ;   et al.
2014-06-12
Combination Therapy With Mdm2 And Efgr Inhibitors
App 20140134163 - Errico; Joseph P. ;   et al.
2014-05-15
Combination therapy with MDM2 and EFGR inhibitors
Grant 8,658,170 - Errico , et al. February 25, 2
2014-02-25
Methods and compositions of targeted drug development
Grant 8,618,302 - Errico , et al. December 31, 2
2013-12-31
Methods and compositions of targeted drug development
Grant 08618302 -
2013-12-31
Combination Therapy With Mdm2 And Efgr Inhibitors
App 20120156197 - Errico; Joseph P. ;   et al.
2012-06-21
Methods And Compositions Of Targeted Drug Development
App 20110301193 - Errico; Joseph P. ;   et al.
2011-12-08
Tartrate salt of isofagomine and methods of use
Grant 7,863,453 - Mugrage , et al. January 4, 2
2011-01-04
Use Of Substrates As Pharmacological Chaperones
App 20100197018 - Mugrage; Benjamin
2010-08-05
Tartrate Salt Of Isofagomine And Methods Of Use
App 20090176830 - Mugrage; Benjamin ;   et al.
2009-07-09
Tartrate salt of isofagomine and methods of use
Grant 7,501,439 - Mugrage , et al. March 10, 2
2009-03-10
Tartrate Salt of Isofagomine and Methods of Use
App 20070281975 - Mugrage; Benjamin ;   et al.
2007-12-06
Method for the treatment of Pompe disease using 1-deoxynojirimycin and derivatives
App 20060264467 - Mugrage; Benjamin ;   et al.
2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed